-
-
-
-
-
-
-
OTR Therapeutics and Zealand Pharma form metabolic disease partnership
-
-
-
-
-
-
-
Zealand Pharma (ZEAL) announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billion
-
-
-
-
-
-
-
Zealand Pharma (ZEAL) announces directed issue and private placement of approximately 6.5 million new shares
-
-
-
-
-
-
-
Zealand Pharma (ZEAL) Announces 4.5M Share Direct Issue
-
-
-
-
-
-
-
Zealand Pharma Provides Update on Refocused Strategy Prioritizing Research and Development
-
-
-
-
-
-
-
Zealand Pharma (ZEAL) Announces Seven-Year, $200M Financial Deal with Oberland Capital
-
-
-
-
-
-
-
Zealand Pharma Launches ZEGALOGUE® (dasiglucagon) Injection and Advances Pipeline Programs Across Multiple Therapeutic Areas
-
1,154,895 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

